235 related articles for article (PubMed ID: 8152532)
1. The quipazine- and TFMPP-increased conditioned avoidance response in rats: role of 5HT1C/5-HT2 receptors.
Alhaider AA; Ageel AM; Ginawi OT
Neuropharmacology; 1993 Dec; 32(12):1427-32. PubMed ID: 8152532
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic investigation of the stimulus properties of 1-(3-trifluoromethylphenyl)piperazine.
Herndon JL; Pierson ME; Glennon RA
Pharmacol Biochem Behav; 1992 Nov; 43(3):739-48. PubMed ID: 1333084
[TBL] [Abstract][Full Text] [Related]
3. Anorexia induced by M-trifluoromethylphenylpiperazine (TFMPP) in rats.
Kłodzińska A; Chojnacka-Wójcik E
Pol J Pharmacol Pharm; 1990; 42(1):13-7. PubMed ID: 2281017
[TBL] [Abstract][Full Text] [Related]
4. Effects of quipazine and m-chlorophenylbiguanide (m-CPBG) on temporal differentiation: evidence for the involvement of 5-HT2A but not 5-HT3 receptors in interval timing behaviour.
Body S; Asgari K; Rickard JF; Zhang Z; Fone KC; Bradshaw CM; Szabadi E
Psychopharmacology (Berl); 2005 Sep; 181(2):289-98. PubMed ID: 15864559
[TBL] [Abstract][Full Text] [Related]
5. Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors.
Kennett GA; Curzon G
Psychopharmacology (Berl); 1988; 96(1):93-100. PubMed ID: 2906446
[TBL] [Abstract][Full Text] [Related]
6. Serotonin and the mammalian circadian system: I. In vitro phase shifts by serotonergic agonists and antagonists.
Prosser RA; Dean RR; Edgar DM; Heller HC; Miller JD
J Biol Rhythms; 1993; 8(1):1-16. PubMed ID: 8490207
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the discriminative stimulus properties induced by 5-HT1 and 5-HT2 agonists in rats.
Arnt J
Pharmacol Toxicol; 1989 Feb; 64(2):165-72. PubMed ID: 2526950
[TBL] [Abstract][Full Text] [Related]
8. Effects of serotonin agonists on operant behavior in the squirrel monkey: quipazine, MK-212, trifluoromethylphenylpiperazine, and chlorophenylpiperazine.
McKearney JW
Pharmacol Biochem Behav; 1990 Jan; 35(1):181-5. PubMed ID: 2315357
[TBL] [Abstract][Full Text] [Related]
9. The inhibitory effect of trifluoromethylphenylpiperazine on [3H]acetylcholine release in guinea pig hippocampal synaptosomes is mediated by a 5-hydroxytryptamine1 receptor distinct from 1A, 1B, and 1C subtypes.
Harel-Dupas C; Cloëz I; Fillion G
J Neurochem; 1991 Jan; 56(1):221-7. PubMed ID: 1824781
[TBL] [Abstract][Full Text] [Related]
10. GR 127935 and (+)-WAY 100135 do not affect TFMPP-induced inhibition of 5-HT synthesis in the midbrain and hippocampus of Wistar-Kyoto rats.
Chaouloff F; Aguerre S; Mormede P
Neuropharmacology; 1998 Sep; 37(9):1159-67. PubMed ID: 9833646
[TBL] [Abstract][Full Text] [Related]
11. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
Titeler M; Lyon RA; Davis KH; Glennon RA
Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239
[TBL] [Abstract][Full Text] [Related]
12. Neurochemical and behavioral evidence that quipazine-ketanserin discrimination is mediated by serotonin2A receptor.
Smith RL; Barrett RJ; Sanders-Bush E
J Pharmacol Exp Ther; 1995 Nov; 275(2):1050-7. PubMed ID: 7473132
[TBL] [Abstract][Full Text] [Related]
13. The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons.
Mos J; Van Hest A; Van Drimmelen M; Herremans AH; Olivier B
Eur J Pharmacol; 1997 May; 325(2-3):145-53. PubMed ID: 9163561
[TBL] [Abstract][Full Text] [Related]
14. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
[TBL] [Abstract][Full Text] [Related]
15. Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors.
Kennett GA; Curzon G
Br J Pharmacol; 1988 May; 94(1):137-47. PubMed ID: 3401632
[TBL] [Abstract][Full Text] [Related]
16. Agonist action at 5-HT1C receptors facilitates 5-HT1A receptor-mediated spontaneous tail-flicks in the rat.
Bervoets K; Millan MJ; Colpaert FC
Eur J Pharmacol; 1990 Nov; 191(2):185-95. PubMed ID: 2150818
[TBL] [Abstract][Full Text] [Related]
17. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
Pauwels PJ; Van Gompel P; Leysen JE
Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063
[TBL] [Abstract][Full Text] [Related]
18. Novel regulation of 5-HT1C receptors: down-regulation induced both by 5-HT1C/2 receptor agonists and antagonists.
Pranzatelli MR; Murthy JN; Tailor PT
Eur J Pharmacol; 1993 Jan; 244(1):1-5. PubMed ID: 8420788
[TBL] [Abstract][Full Text] [Related]
19. The 5-HT1A receptor agonist flesinoxan shares discriminative stimulus properties with some 5-HT2 receptor antagonists.
Herremans AH; van der Heyden JA; van Drimmelen M; Olivier B
Pharmacol Biochem Behav; 1999 Oct; 64(2):389-95. PubMed ID: 10515319
[TBL] [Abstract][Full Text] [Related]
20. Possible 5-hydroxytryptamine1 (5-HT1) receptor involvement in the stimulus properties of 1-(m-trifluoromethylphenyl)piperazine (TFMPP).
Cunningham KA; Appel JB
J Pharmacol Exp Ther; 1986 May; 237(2):369-77. PubMed ID: 2939233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
